Top Markets
Coin of the day
Caregen Co., Ltd. Caregen Co., Ltd.

Caregen Co., Ltd.

214370
Rank in Stocks #6970
Caregen Co., Ltd. is primarily involved in the creation and development of... Caregen Co., Ltd. is primarily involved in the creation and development of biomimetic peptides. The company operates through distinct business segments, each catering to specific markets. Its Professional Therapy division engineers medical devices utilizing functional peptides and sophisticated sustained-release technology. Through its Cosmeceutical line, Caregen offers a variety of products for skin and hair care, including solutions for whitening, anti-inflammatory purposes, and those mimicking botulinum toxin functions. The Health Functional Food division provides dietary supplements specifically designed for blood control. Additionally, the Raw Material segment supplies essential peptide growth factors. Founded on August 17, 2001, the firm is headquartered in Anyang-si, South Korea.
Share Price
$36.30
Market Cap
$1.77B
Change (1 day)
-1.32%
Change (1 year)
-5.99%
Country
KR
Trade Caregen Co., Ltd. (214370)
Revenue for Caregen Co., Ltd. (214370)
Revenue in Aug 2026 TTM: 0
According to Caregen Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Caregen Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors